MES-like cells in NF1-mutant glioblastomas demonstrated significantly increased expression of transcriptional MEK activation and MEK/ERK target gene signatures compared with non-MES cells (Figure 2, D and E, and Supplemental Figure 5, C and D) (30, 31). This evidence concerns the gene MAP2K7 and glioblastoma.